Cargando…

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction

BACKGROUND: Familial hypercholesterolemia (FH) is a genetic cause of premature myocardial infarction (PMI). Early diagnosis of FH is critical for prognosis. HYPOTHESIS: To investigate the prevalence of FH among a cohort of Chinese patients with PMI using genetic testing, and to evaluate different di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yuxia, Li, Sufang, Zhang, Feng, Song, Junxian, Lee, Chongyou, Wu, Manyan, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712327/ https://www.ncbi.nlm.nih.gov/pubmed/30637778 http://dx.doi.org/10.1002/clc.23154

Ejemplares similares

Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction
por: Lee, Chongyou, et al.
Publicado: (2019)

Digenic mutations on SCAP and AGXT2 predispose to premature myocardial infarction
por: Gao, Yuanfeng, et al.
Publicado: (2017)

Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner: A systematic review and meta-analysis
por: Li, Changlong, et al.
Publicado: (2017)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction
por: Liu, Chuanfen, et al.
Publicado: (2023)

Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up
por: Auckle, Ranshaka, et al.
Publicado: (2017)

A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia
por: Sun, Di, et al.
Publicado: (2019)

Circulating microRNAs as potential biomarkers for coronary plaque rupture
por: Li, Sufang, et al.
Publicado: (2017)

Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia
por: Zhao, Pei Jun, et al.
Publicado: (2019)

Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction
por: Zhang, Min, et al.
Publicado: (2021)

Exploratory echocardiographic strain parameters for the estimation of myocardial infarct size in ST‐elevation myocardial infarction
por: Dannenberg, Varius, et al.
Publicado: (2021)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
por: Brænne, Ingrid, et al.
Publicado: (2014)

The prevalence of 30‐day readmission after acute myocardial infarction: A systematic review and meta‐analysis
por: Wang, Huijie, et al.
Publicado: (2019)

Timing of initiation of intra‐aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: A meta‐analysis
por: Cui, Kongyong, et al.
Publicado: (2019)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease
por: Pirazzi, Carlo, et al.
Publicado: (2019)

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
por: Puymirat, Etienne, et al.
Publicado: (2018)

Appropriateness of gastrointestinal prophylaxis use during hospitalization in patients with acute myocardial infarction: Analysis from the China Acute Myocardial Infarction Registry
por: Shi, Wence, et al.
Publicado: (2020)

Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction
por: Chen, Qixin, et al.
Publicado: (2021)

Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction
por: Zhang, Enyuan, et al.
Publicado: (2015)

Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic‐cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2020)

The association between anxiety disorders and in‐hospital outcomes in patients with myocardial infarction
por: Li, Pengyang, et al.
Publicado: (2020)

Management and outcome across the spectrum of high‐risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk‐score for secondary prevention
por: Grinberg, Tzlil, et al.
Publicado: (2021)

Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand
por: Kumar, Prakash, et al.
Publicado: (2022)

Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia
por: Fahed, Akl C., et al.
Publicado: (2017)

Non‐ST‐elevated myocardial infarction with “N” wave on electrocardiogram and culprit vessel in left circumflex has a risk equivalent to ST‐elevated myocardial infarction
por: Yang, Tiangui, et al.
Publicado: (2020)

Mortality differences among patients with in‐hospital ST‐elevation myocardial infarction
por: Shahandeh, Negeen, et al.
Publicado: (2020)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

Comparison of coronary atherosclerotic disease burden between ST‐elevation myocardial infarction and non‐ST‐elevation myocardial infarction: Non‐culprit Gensini score and non‐culprit SYNTAX score
por: Tanaka, Takamasa, et al.
Publicado: (2020)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction
por: Chehab, Omar, et al.
Publicado: (2019)

Sex differences in treatment and outcomes of patients with in‐hospital ST‐elevation myocardial infarction
por: Stehli, Julia, et al.
Publicado: (2022)

Decreased miR-92a-3p expression potentially mediates the pro-angiogenic effects of oxidative stress-activated endothelial cell-derived exosomes by targeting tissue factor
por: Li, Sufang, et al.
Publicado: (2020)

Outcomes after readmission at the index or nonindex hospital following acute myocardial infarction complicated by cardiogenic shock
por: Lin, Zhen, et al.
Publicado: (2021)

Cardiology clinic visit increases likelihood of evidence‐based cholesterol prescribing in severe hypercholesterolemia
por: Groth, Nicole A., et al.
Publicado: (2020)

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population
por: Li, Suying, et al.
Publicado: (2019)

Influence of seasons on the management and outcomes acute myocardial infarction: An 18‐year US study
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2020)

Prognostic value of admission electrocardiographic findings in non‐ST‐segment elevation myocardial infarction
por: Chen, Peng‐fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41gsrqvm99fjoguaprcpeqhbfa